MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 8761-8770 Newer>
The Motley Fool
July 28, 2005
Tim Beyers
A Taxing Quarter for Bristol-Myers Squibb: Fool by Numbers The pharma released second quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles 2155 similar articles
The Motley Fool
July 28, 2005
Tom Taulli
Banking on Bankrate Much has happened at Bankrate, and much of it appears to be good. Despite the company's reliance on several macro factors, this stock is a buy. mark for My Articles 30 similar articles
The Motley Fool
July 28, 2005
Stephen D. Simpson
A Patchy Quarter for Apache The oil producer's shares stumble on a slight earnings miss, but this company is a proven winner. mark for My Articles 310 similar articles
The Motley Fool
July 28, 2005
Stephen D. Simpson
Aetna's Affirmation Aetna posts solid results as health-care costs grow moderately. The health care insurer's relative valuation would seem to at least make it worth a second look for now. mark for My Articles 203 similar articles
The Motley Fool
July 28, 2005
Tom Taulli
Is Sun Getting Eclipsed? Maybe the best strategy for Sun is just to give money back to its shareholders. mark for My Articles 797 similar articles
The Motley Fool
July 28, 2005
W.D. Crotty
Dow Chemical's Oversized Profits Dow sets records in its latest quarter, though weak volume offset strong pricing. mark for My Articles 417 similar articles
The Motley Fool
July 28, 2005
Nathan Slaughter
MGM Mirage Is No Illusion The gaming giant posts solid second quarter results after Mandalay Bay acquisition. mark for My Articles 663 similar articles
The Motley Fool
July 28, 2005
Alyce Lomax
Starbucks' Summer Sizzles Investors find a lot to like in Starbucks' third-quarter earnings numbers. mark for My Articles 490 similar articles
The Motley Fool
July 28, 2005
Stephen D. Simpson
Respironics Still Breathes Freely Despite years of solid growth from Respironics, the respiratory market is still underserved and unappreciated. The history of the past few years would suggest you'll get another chance to buy these shares at a somewhat better valuation. mark for My Articles 9 similar articles
The Motley Fool
July 28, 2005
Tim Beyers
Akamai Hangs Ten The content delivery specialist's sales and earnings scream 'cowabunga!' as guidance crests the wave. mark for My Articles 119 similar articles
<Older 8761-8770 Newer>    Return to current articles.